UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (11153) 11153
Newsletter (235) 235
Magazine Article (89) 89
Newspaper Article (82) 82
Book Chapter (8) 8
Book / eBook (7) 7
Web Resource (5) 5
Dissertation (4) 4
Government Document (4) 4
Conference Proceeding (3) 3
Transcript (3) 3
Streaming Video (2) 2
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (9480) 9480
science & technology (6407) 6407
life sciences & biomedicine (5996) 5996
antitubercular agents - administration & dosage (5319) 5319
male (4855) 4855
tuberculosis (4836) 4836
female (4626) 4626
antitubercular agents - therapeutic use (4427) 4427
adult (3887) 3887
tuberculosis, pulmonary - drug therapy (2894) 2894
middle aged (2890) 2890
tuberculosis - drug therapy (2469) 2469
infectious diseases (2151) 2151
antitubercular agents (2097) 2097
drug therapy, combination (1999) 1999
treatment outcome (1781) 1781
adolescent (1683) 1683
aged (1547) 1547
mycobacterium tuberculosis - drug effects (1486) 1486
drug therapy (1443) 1443
animals (1354) 1354
respiratory system (1346) 1346
antitubercular agents - adverse effects (1342) 1342
isoniazid - administration & dosage (1275) 1275
pharmacology & pharmacy (1235) 1235
rifampin - administration & dosage (1210) 1210
antitubercular agents - pharmacology (1188) 1188
microbiology (1162) 1162
child (1080) 1080
tuberculosis, multidrug-resistant - drug therapy (1073) 1073
time factors (1059) 1059
drug administration schedule (1041) 1041
abridged index medicus (997) 997
drug resistance (986) 986
general & internal medicine (940) 940
care and treatment (915) 915
risk factors (905) 905
immunology (888) 888
research (886) 886
isoniazid - therapeutic use (864) 864
mycobacterium tuberculosis - isolation & purification (854) 854
dosage and administration (840) 840
young adult (830) 830
mycobacterium tuberculosis (795) 795
rifampin - therapeutic use (773) 773
retrospective studies (744) 744
isoniazid (743) 743
medicine, general & internal (723) 723
tuberculosis - prevention & control (719) 719
health aspects (707) 707
tuberculosis - epidemiology (705) 705
child, preschool (690) 690
analysis (670) 670
research article (651) 651
tuberculosis - diagnosis (647) 647
antitubercular agents - pharmacokinetics (641) 641
microbial sensitivity tests (640) 640
follow-up studies (621) 621
medicine (620) 620
drugs (607) 607
mice (597) 597
tuberculosis, pulmonary - diagnosis (572) 572
rifampin (565) 565
patients (564) 564
infant (557) 557
hiv (536) 536
pyrazinamide - administration & dosage (536) 536
diagnosis (533) 533
hiv infections - complications (502) 502
sputum - microbiology (498) 498
tuberculosis, pulmonary - microbiology (497) 497
hiv infections - drug therapy (495) 495
human immunodeficiency virus--hiv (485) 485
ethambutol - administration & dosage (479) 479
patient compliance (478) 478
public health (474) 474
tuberculosis - microbiology (462) 462
drug resistance in microorganisms (461) 461
infections (436) 436
antibiotics, antitubercular - administration & dosage (431) 431
prospective studies (428) 428
tuberculosis, multidrug-resistant - epidemiology (425) 425
old medline (404) 404
tuberculosis, pulmonary - epidemiology (401) 401
aged, 80 and over (394) 394
antibiotics, antitubercular (393) 393
drug resistance, microbial (392) 392
tuberculosis - complications (388) 388
incidence (387) 387
drug interactions (385) 385
medical research (385) 385
dose-response relationship, drug (381) 381
science & technology - other topics (379) 379
aids/hiv (377) 377
public, environmental & occupational health (375) 375
pharmacology (373) 373
isoniazid - adverse effects (365) 365
multidisciplinary sciences (364) 364
recurrence (362) 362
diagnosis, differential (356) 356
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (9692) 9692
Russian (800) 800
Japanese (376) 376
German (314) 314
French (295) 295
Spanish (154) 154
Italian (94) 94
Portuguese (94) 94
Polish (82) 82
Chinese (65) 65
Romanian (59) 59
Dutch (25) 25
Ukrainian (12) 12
Croatian (11) 11
Danish (11) 11
Norwegian (11) 11
Turkish (11) 11
Czech (9) 9
Serbian (8) 8
Hebrew (7) 7
Korean (6) 6
Swedish (6) 6
Hungarian (5) 5
Finnish (4) 4
Bulgarian (3) 3
Lithuanian (3) 3
Slovak (2) 2
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet infectious diseases, ISSN 1473-3099, 2013, Volume 13, Issue 1, pp. 27 - 35
Journal Article
Archives of Dermatological Research, ISSN 0340-3696, 1/2009, Volume 301, Issue 1, pp. 99 - 105
Drug-induced lupus erythematosus (DILE) is defined as a lupus-like syndrome temporally related to continuous drug exposure which resolves after discontinuation... 
Drug-induced lupus erythematosus | Antinuclear antibodies (ANA) | Medicine & Public Health | Dermatology | Anti-TNFα-induced lupus | Anti-histone antibodies | Subacute cutaneous drug-induced lupus (SCLE) | Drug reactions | Life Sciences & Biomedicine | Science & Technology | Antifungal Agents - adverse effects | Antitubercular Agents - adverse effects | Naphthalenes - adverse effects | Antibodies - metabolism | Calcium Channel Blockers - adverse effects | Serositis | Exanthema | Humans | Isoniazid - adverse effects | Interferons - adverse effects | Antihypertensive Agents - administration & dosage | Sodium Chloride Symporter Inhibitors - adverse effects | Arthritis | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Lupus Erythematosus, Systemic - immunology | Sodium Chloride Symporter Inhibitors - administration & dosage | Tumor Necrosis Factor-alpha - immunology | Antibodies - immunology | Lupus Erythematosus, Cutaneous - chemically induced | Procainamide - administration & dosage | Lupus Erythematosus, Cutaneous - immunology | Angiotensin-Converting Enzyme Inhibitors - administration & dosage | Anti-Arrhythmia Agents - administration & dosage | Procainamide - adverse effects | Antihypertensive Agents - adverse effects | Hydralazine - adverse effects | Isoniazid - administration & dosage | Lupus Erythematosus, Systemic - diagnosis | Interferons - administration & dosage | Hydralazine - administration & dosage | Animals | Anti-Arrhythmia Agents - adverse effects | Naphthalenes - administration & dosage | Calcium Channel Blockers - administration & dosage | Antitubercular Agents - administration & dosage | Lupus Erythematosus, Systemic - chemically induced | Antifungal Agents - administration & dosage | Lupus Erythematosus, Cutaneous - diagnosis | Lupus | Antigen-antibody reactions | Enzymes | Antigens | Biological products | Antibodies | Viral antibodies | Enzyme inhibitors | Systemic lupus erythematosus | Fluocinolone acetonide | Calcium channel blockers | Diuretics | Kidney diseases | Hydralazine | Index Medicus
Journal Article
The European respiratory journal, ISSN 0903-1936, 04/2012, Volume 39, Issue 4, pp. 956 - 962
Journal Article
by Danel, Christine and Moh, Raoul and Gabillard, Delphine and Badje, Anani and Le Carrou, Jérôme and Ouassa, Timothée and Ouattara, Eric and Anzian, Amani and Ntakpé, Jean-Baptiste and Minga, Albert and Kouame, Gérard M and Bouhoussou, Franck and Emieme, Arlette and Kouamé, Antoine and Inwoley, André and Toni, Thomas-D'Aquin and Ahiboh, Hugues and Kabran, Mathieu and Rabe, Cyprien and Sidibé, Baba and Nzunetu, Gustave and Konan, Romuald and Gnokoro, Joachim and Gouesse, Patrice and Messou, Eugène and Dohoun, Lambert and Kamagate, Synali and Yao, Abo and Amon, Solange and Kouame, Amadou-Barenson and Koua, Aboli and Kouamé, Emmanuel and Ndri, Yao and Ba-Gomis, Olivier and Daligou, Marcelle and Ackoundzé, Simplice and Hawerlander, Denise and Ani, Alex and Dembéle, Fassery and Koné, Fatoumata and Guéhi, Calixte and Kanga, Constance and Koule, Serge and Séri, Jonas and Oyebi, Mykayila and Mbakop, Nathalie and Makaila, Olewole and Babatunde, Carole and Babatounde, Nathanael and Bleoué, Gisèle and Tchoutedjem, Mireille and Kouadio, Alain-Claude and Sena, Ghislaine and Yededji, Sahinou-Yediga and Assi, Rodrigue and Bakayoko, Alima and Mahassadi, Alassane and Attia, Alain and Oussou, Armel and Mobio, Max and Bamba, Doféré and Koman, Mesmin and Horo, Apollinaire and Deschamps, Nina and Chenal, Henri and Sassan-Morokro, Madeleine and Konate, Seidou and Aka, Kakou and Aoussi, Eba and Journot, Valérie and Nchot, Célestin and Karcher, Sophie and Chaix, Marie-Laure and Rouzioux, Christine and Sow, Papa-Salif and Perronne, Christian and Girard, Pierre-Marie and Menan, Hervé and Bissagnene, Emmanuel and Kadio, Auguste and Ettiegne-Traore, Virginie and Moh-Semdé, Corinne and Kouame, Abo and Massumbuko, Jean-Marie and Chêne, Geneviève and Dosso, Mireille and Domoua, Serge K and N'Dri-Yoman, Thérèse and Salamon, Roger and Eholié, Serge P and Anglaret, Xavier and The TEMPRANO ANRS 12136 Study Group and TEMPRANO ANRS 12136 Study Group
The New England journal of medicine, ISSN 1533-4406, 08/2015, Volume 373, Issue 9, pp. 808 - 822
Journal Article
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 06/2012, Volume 56, Issue 6, pp. 3027 - 3031
Journal Article